Vermillion to Present at the Canaccord Genuity 37th Annual Growth Conference on August 10th


Valerie Palmieri, President and Chief Executive Officer of Vermillion Inc., will provide a corporate overview at the Canaccord Genuity 37th Annual Growth Conference, being held August 9-10 in Boston, Massachusetts.


Presentation Details

Date:                           Thursday, August 10

Time:                          1:00pm Eastern Time

Location:                    InterContinental Boston Hotel, Hong Kong Room

Canaccord Tenuity, Medical Technologies & Diagnostics Forum

November 17, 2016

Westin Grand Central Hotel

New York, New York

AAGL 45th Annual Global Congress

November 14-18, 2016

The Rosen Hotel

Orlando, Florida

Third Quarter 2016 Financial Results and Investor Conference Call

November 10, 2016 at 4:30 p.m. EST

Join by phone:

  • Domestic: 1-888-296-4197
  • International: 1-719-2462
  • Conference ID: 6709878

Join by webcast, here.

Replay dial-in numbers (available through): November 24, 2016

  • Domestic: 1-844-512-2921
  • International: 1-412-317-6671
  • Replay PIN: 6709878


Understanding New Changes to the OVA1 Results Report

November 3, 3016

East Coast: 12:30-12:45 p.m. EST

West Coast: 12:30-12:45 p.m. PST

Presented by: Dr. Marra Francis, Chief Medical Officer of Vermillion and Dr. Herb Fritsche, Lab Director of ASPiRA Labs

Register for East Coast, here.

Register for West Coast, here.

For Investors

A Vermillion Investor Overview

We are dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve outcomes for women.